Novel biomarkers predict prognosis and drug-induced neuroendocrine differentiation in patients with prostate cancer

Abstract

This study revealed the heterogeneity between CRPC and CRPC-NE from different perspectives, and developed a reliable diagnostic model of CRPC-NE and robust prognostic models for PCa.